Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.
about
Devices in the management of advanced, chronic heart failureMechanical circulatory support in the new era: an overviewAnticoagulation management in mechanical circulatory supportChronic outpatient management of patients with a left ventricular assist deviceVon Willebrand factor in patients on mechanical circulatory support - a double-edged sword between bleeding and thrombosisLate Complications Following Continuous-Flow Left Ventricular Assist Device ImplantationMechanical Ventricular Assistance as Destination Therapy for End-Stage Heart Failure: Has it Become a First Line Therapy?Advanced therapies for end-stage heart failureGastrointestinal bleeding after continuous-flow left ventricular device implantation: review of pathophysiology and managementIn microfluidico: Recreating in vivo hemodynamics using miniaturized devicesComplications of Continuous-Flow Mechanical Circulatory Support Devices.Gastrointestinal bleeding in patients with ventricular assist devices: what every cardiac nurse should know.Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy.A quantitative comparison of mechanical blood damage parameters in rotary ventricular assist devices: shear stress, exposure time and hemolysis index.Relation of preoperative serum albumin levels to survival in patients undergoing left ventricular assist device implantation.In vivo testing of a novel blood pump for short-term extracorporeal life support.Medical management of patients with continuous-flow left ventricular assist devices.Gastrointestinal bleed after left ventricular assist device implantation: incidence, management, and preventionHypertension: an unstudied potential risk factor for adverse outcomes during continuous flow ventricular assist device supportAcute and critically ill peripartum cardiomyopathy and 'bridge to' therapeutic options: a single center experience with intra-aortic balloon pump, extra corporeal membrane oxygenation and continuous-flow left ventricular assist devicesEffects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian centerThromboembolic stroke in patients with a HeartMate-II left ventricular assist device - the role of anticoagulationWhat is the optimal anticoagulation in patients with a left ventricular assist device?Perioperative onset of acquired von Willebrand syndrome: Comparison between HVAD, HeartMate II and on-pump coronary bypass surgery.Major themes for 2010 in cardiothoracic and vascular anesthesia.Severe thrombotic and bleeding complications in a baby with heterozygous factor V Leiden and acquired von Willebrand disease on ECMO.Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study.The Native Kidney Biopsy: Update and Evidence for Best Practice.The Heartmate Risk Score predicts morbidity and mortality in unselected left ventricular assist device recipients and risk stratifies INTERMACS class 1 patients.Direct observation of von Willebrand factor elongation and fiber formation on collagen during acute whole blood exposure to pathological flow.Video capsule endoscopy in left ventricular assist device recipients with obscure gastrointestinal bleedingRelationship Between Anticoagulation Intensity and Thrombotic or Bleeding Outcomes Among Outpatients With Continuous-Flow Left Ventricular Assist Devices.Acquired von Willebrand syndrome associated with left ventricular assist device.Contemporary strategies in the diagnosis and management of heart failureMechanical blood trauma in assisted circulation: sublethal RBC damage preceding hemolysis.Evaluation of GI bleeding after implantation of left ventricular assist device.Assessing Consequences of Intraaortic Balloon Counterpulsation Versus Left Ventricular Assist Devices at the Time of Heart Transplantation.Platelet glycoprotein Ibα ectodomain shedding and non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist devices.Close antiplatelet therapy monitoring and adjustment based upon thrombelastography may reduce late-onset bleeding in HeartMate II recipients.Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure -1 year results from the Ce mark trial.
P2860
Q24630052-5A1FC29E-D96E-45EF-B423-DD7ADC0F3B86Q26764936-200C1C9B-7772-4609-8EFB-C216E2FA6EA8Q26770302-E54D97AC-12FB-45DA-A85F-7CA53B8D587BQ26770308-0D530B50-E89B-4FEE-B10D-E9E456CC7A56Q26772079-0DF6AFD8-3ACA-4B32-AAE5-C0E7A26E23E5Q26782700-96512C7B-741B-4272-9144-027E77F94026Q26797254-4C298B7A-B353-4190-8516-CCE991250032Q26992073-44DA304D-A12F-4379-BABF-3144E2170356Q27007485-DAD0C308-FBB7-4B08-A30D-0A6D3E8F5EA1Q28084800-57ED2EC8-09F4-491F-9181-477BF2986878Q30409848-43C5F4ED-F44F-48D5-A41E-368DF234ED3BQ30456938-080FD26F-7923-45B8-89F5-B2D791C7D182Q33421552-3A3E88FD-2801-43FC-A4D4-77352B6A5CE5Q33626799-2E36C9A1-207D-4710-AB6E-76DBBEE5DBCEQ33818507-6811628A-6E0A-46DB-99E9-A1A66EB5D9CCQ33899171-7C500ADB-5DA6-4F8E-B418-EE9DB61068BFQ34152572-111AE384-16A7-4826-ACC8-80A55C970707Q34498773-9DC17771-9435-4CB4-9355-A6D28812B9A2Q35272280-7FE1E5B3-BF63-467A-9499-811730F4FCADQ35559442-D8913866-65BD-40A1-8E27-2CD46E5018B1Q36093132-B4D195BA-AE01-4075-B898-0E3ED6AE6CEAQ36163829-0413F6BF-C55B-484A-9958-62E38AD602FAQ36242928-54D9095D-E8CE-4E0F-867A-E99523306A0AQ36289557-9EA683CB-02E1-4885-85AA-A699373B6DA4Q36358323-935AD52E-4359-4CBF-8A11-1814E83DEDF7Q36374435-C3E6051F-584E-485A-B79F-368642E6DF36Q36534319-61523AF9-FD55-43D1-87F6-0EB0CEC0B69EQ36543064-F66A4B43-31FA-48E6-A5B3-666FF73FE231Q36618293-00199934-356A-45F8-A9A5-508EA6BB9C9DQ36677412-FBCA6319-D91C-4DDA-8748-E73861407A3CQ36875044-C85453ED-29C1-47FD-9001-D26E9D98E108Q36881923-0E917DD8-D788-4CD1-AA41-8BFA3042FCEFQ37035825-81B02EE7-6FDC-4F0C-A7B8-2E264B740452Q37041145-C4D5DD0E-C95A-4BCC-BCF8-E858516F1416Q37055464-F8BF7E2B-1864-4237-8C2C-CDF72F64F703Q37330277-E121A0D5-BFE6-457B-88A4-925B06F3E6BEQ37514357-82FF4241-524C-4AA3-B6E8-9FF406A5B206Q37625884-27964A79-322F-427F-ABA7-C23C4175A2F3Q37642744-31D77121-B023-41A5-98C6-EDF3D2F4D671Q37736683-CBBDD2A2-EA0E-4A98-A6CD-F4F6C8C2B97B
P2860
Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Acquired von Willebrand syndro ...... t the time of transplantation.
@ast
Acquired von Willebrand syndro ...... t the time of transplantation.
@en
Acquired von Willebrand syndro ...... t the time of transplantation.
@nl
type
label
Acquired von Willebrand syndro ...... t the time of transplantation.
@ast
Acquired von Willebrand syndro ...... t the time of transplantation.
@en
Acquired von Willebrand syndro ...... t the time of transplantation.
@nl
prefLabel
Acquired von Willebrand syndro ...... t the time of transplantation.
@ast
Acquired von Willebrand syndro ...... t the time of transplantation.
@en
Acquired von Willebrand syndro ...... t the time of transplantation.
@nl
P2093
P1476
Acquired von Willebrand syndro ...... t the time of transplantation.
@en
P2093
Andre Vincentelli
Brigitte Jude
Donna Mancini
Pierre-Vladimir Ennezat
Sang-Woo Pak
Sarah Cappleman
Sophie Susen
Ulrich P Jorde
Yoshifumi Naka
P304
P356
10.1016/J.JACC.2010.05.016
P407
P577
2010-07-02T00:00:00Z